In order to test the usefulness of the in vitro HRP-labeling technique in the brains of small lizards, the fasciculus retroflexus was labeled in isolated brains of young specimens of the lizard Gallotia galloti by means of HRP applied with the tip of a micropipette located approximately midway along the descending course of the tract. Cells in the medial and lateral habenular nuclei were labeled retrogradely. Anterograde transport showed the course of the fasciculus retroflexus, first dorsoventrally into the paramedian prerubral tegmentum and then longitudinally into the isthmic nucleus interpeduncularis. Some fibers spread dorsally into the mesencephalic and isthmic tegmental fields. A substantial bundle continues caudally into nucleus raphe parvocellularis. Other fibers diverge rostral-wards from the point of inflexion of the fasciculus, coursing longitudinally in the medial forebrain bundle into the basal telencephalon. Some fibers course rostrally from the nucleus habenularis lateralis in the stria medullaris and could be followed to the dorsal septum.

Keywords:
Fasciculus retroflexus, Habenular nuclei, Nucleus interpeduncularis, Stria medullaris, In vitro labeling
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.